Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/EBITDA ratio high or low?
The EV/EBITDA ratio of 25.01x is 19% above its estimated 5-year average of 20.94x, near the high end of its estimated 5-year range (16.48x–26.06x).
As of 2026-09-10T19:59:59.000Z. 13.39% above its estimated 12-month average of 22.06x.
Quote observation: 2026-09-10T19:59:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8233e5283909ab17bac4fe0d43cc0ba3aba61090fff26db7a4ef3d6a4b71faa0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
25.01x
EV/EBITDA RATIO AVG TTM
22.06x
EV/EBITDA RATIO AVG 3Y
21.66x
EV/EBITDA RATIO AVG 5Y
20.94x
EV/EBITDA RATIO AVG 10Y
20.59x
EV/EBITDA RATIO AVG 15Y
18.97x
EV/EBITDA RATIO AVG 20Y
17.61x
CURRENT VS TTM AVG
+13.39%
CURRENT VS 3Y AVG
+15.45%
CURRENT VS 5Y AVG
+19.42%
CURRENT VS 10Y AVG
+21.49%
CURRENT VS 15Y AVG
+31.83%
CURRENT VS 20Y AVG
+42.04%
SECTOR MEDIAN · HEALTHCARE
15.96x
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+56.66%
vs the sector median at left
Thermo Fisher Scientific Inc.
Market Cap
$224.14B
EV/EBITDA Ratio
25.01x
TTM Avg
22.06x
3Y Avg
21.66x
5Y Avg
20.94x
Market Cap
$247.55B
EV/EBITDA Ratio
13.52x
TTM Avg
16.39x
3Y Avg
16.93x
5Y Avg
20.64x
Market Cap
$179.79B
EV/EBITDA Ratio
N/A
TTM Avg
44.93x
3Y Avg
29.05x
5Y Avg
21.84x
Market Cap
$178.87B
EV/EBITDA Ratio
18.95x
TTM Avg
19.15x
3Y Avg
20.63x
5Y Avg
19.24x
Market Cap
$141.00B
EV/EBITDA Ratio
22.59x
TTM Avg
21.35x
3Y Avg
23.29x
5Y Avg
21.63x
Market Cap
$130.60B
EV/EBITDA Ratio
24.83x
TTM Avg
25.25x
3Y Avg
24.48x
5Y Avg
21.35x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $224.14B | 25.01x | 22.06x | 21.66x | 20.94x |
| Amgen Inc. (AMGN)vs › | $206.42B | N/A | 15.41x | 16.32x | 15.13x |
| AstraZeneca PLC (AZN)vs › | $247.55B | 13.52x | 16.39x | 16.93x | 20.64x |
| Novo Nordisk A/S (NVO)vs › | $195.52B | 8.01x | 9.46x | 20.12x | 22.33x |
| Gilead Sciences, Inc. (GILD)vs › | $179.79B | N/A | 44.93x | 29.05x | 21.84x |
| Abbott Laboratories (ABT)vs › | $178.87B | 18.95x | 19.15x | 20.63x | 19.24x |
| Pfizer Inc. (PFE)vs › | $157.53B | 10.13x | 9.20x | 13.58x | 11.95x |
| Danaher Corporation (DHR)vs › | $141.00B | 22.59x | 21.35x | 23.29x | 21.63x |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.60B | 24.83x | 25.25x | 24.48x | 21.35x |
| Bristol-Myers Squibb Company (BMY)vs › | $130.21B | 9.72x | 8.45x | 8.06x | 8.70x |
At 25.0, EV/EBITDA is above its estimated 20-year median — higher than 95% of readings in its estimated 20-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 20-year low
6.8
median
18.3
estimated 20-year high
53.1
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-09-09 | 25.07x |
| 2026-09-08 | 24.97x |
| 2026-09-04 | 25.35x |
| 2026-09-03 | 25.52x |
| 2026-09-02 | 25.17x |
| 2026-09-01 | 24.88x |
| 2026-08-31 | 25.47x |
| 2026-08-28 | 25.65x |
| 2026-08-27 | 25.95x |
| 2026-08-26 | 26.06x |
| 2026-08-25 | 25.86x |
| 2026-08-24 | 25.88x |
| 2026-08-21 | 25.90x |
| 2026-08-20 | 25.84x |
| 2026-08-19 | 25.34x |
| 2026-08-18 | 24.48x |
| 2026-08-17 | 24.35x |
| 2026-08-14 | 24.45x |
| 2026-08-13 | 24.72x |
| 2026-08-12 | 24.97x |
| 2026-08-11 | 25.04x |
| 2026-08-10 | 24.85x |
| 2026-08-07 | 24.65x |
| 2026-08-06 | 24.16x |
| 2026-08-05 | 24.08x |
| 2026-08-04 | 23.62x |
| 2026-08-03 | 23.95x |
| 2026-07-31 | 24.13x |
| 2026-07-30 | 24.22x |
| 2026-07-29 | 24.21x |
| 2026-07-28 | 24.21x |
| 2026-07-27 | 23.61x |
| 2026-07-24 | 23.92x |
| 2026-07-23 | 24.06x |
| 2026-07-22 | 22.44x |
| 2026-07-21 | 22.33x |
| 2026-07-20 | 22.43x |
| 2026-07-17 | 22.65x |
| 2026-07-16 | 23.03x |
| 2026-07-15 | 22.75x |
| 2026-07-14 | 22.71x |
| 2026-07-13 | 22.51x |
| 2026-07-10 | 22.46x |
| 2026-07-09 | 22.38x |
| 2026-07-08 | 21.86x |
| 2026-07-07 | 22.09x |
| 2026-07-06 | 22.12x |
| 2026-07-02 | 22.33x |
| 2026-07-01 | 21.97x |
| 2026-06-30 | 21.55x |
| 2026-06-29 | 21.73x |
| 2026-06-26 | 21.96x |
| 2026-06-25 | 21.70x |
| 2026-06-24 | 21.22x |
| 2026-06-23 | 20.42x |
| 2026-06-22 | 20.23x |
| 2026-06-18 | 20.25x |
| 2026-06-17 | 20.14x |
| 2026-06-16 | 20.53x |
| 2026-06-15 | 20.57x |
| 2026-06-12 | 20.42x |
| 2026-06-11 | 20.64x |
| 2026-06-10 | 20.86x |
| 2026-06-09 | 21.29x |
| 2026-06-08 | 20.43x |
| 2026-06-05 | 20.54x |
| 2026-06-04 | 20.86x |
| 2026-06-03 | 20.58x |
| 2026-06-02 | 20.87x |
| 2026-06-01 | 21.29x |
| 2026-05-29 | 21.24x |
| 2026-05-28 | 21.05x |
| 2026-05-27 | 19.95x |
| 2026-05-26 | 19.67x |
| 2026-05-22 | 19.67x |
| 2026-05-21 | 19.71x |
| 2026-05-20 | 19.79x |
| 2026-05-19 | 19.65x |
| 2026-05-18 | 19.45x |
| 2026-05-15 | 19.32x |
| 2026-05-14 | 19.67x |
| 2026-05-13 | 19.59x |
| 2026-05-12 | 20.06x |
| 2026-05-11 | 19.82x |
| 2026-05-08 | 20.26x |
| 2026-05-07 | 20.60x |
| 2026-05-06 | 20.54x |
| 2026-05-05 | 20.32x |
| 2026-05-04 | 20.18x |
| 2026-05-01 | 19.15x |
| 2026-04-30 | 19.49x |
| 2026-04-29 | 19.04x |
| 2026-04-28 | 19.18x |
| 2026-04-27 | 19.10x |
| 2026-04-24 | 19.16x |
| 2026-04-23 | 19.06x |
| 2026-04-22 | 20.71x |
| 2026-04-21 | 21.08x |
| 2026-04-20 | 21.13x |
| 2026-04-17 | 21.15x |
| 2026-04-16 | 20.78x |
| 2026-04-15 | 21.33x |
| 2026-04-14 | 21.17x |
| 2026-04-13 | 20.72x |
| 2026-04-10 | 20.09x |
| 2026-04-09 | 20.24x |
| 2026-04-08 | 20.34x |
| 2026-04-07 | 19.85x |
| 2026-04-06 | 19.81x |
| 2026-04-02 | 19.92x |
| 2026-04-01 | 20.03x |
| 2026-03-31 | 19.93x |
| 2026-03-30 | 19.52x |
| 2026-03-27 | 19.29x |
| 2026-03-26 | 19.83x |
| 2026-03-25 | 19.90x |
| 2026-03-24 | 19.88x |
| 2026-03-23 | 19.46x |
| 2026-03-20 | 19.33x |
| 2026-03-19 | 19.18x |
| 2026-03-18 | 18.99x |
| 2026-03-17 | 19.27x |
| 2026-03-16 | 19.17x |
| 2026-03-13 | 18.98x |
| 2026-03-12 | 19.38x |
| 2026-03-11 | 20.07x |
| 2026-03-10 | 20.22x |
| 2026-03-09 | 20.57x |
| 2026-03-06 | 20.29x |
| 2026-03-05 | 20.88x |
| 2026-03-04 | 20.67x |
| 2026-03-03 | 20.51x |
| 2026-03-02 | 20.52x |
| 2026-02-27 | 20.96x |
| 2026-02-26 | 21.40x |
| 2026-02-25 | 21.17x |
| 2026-02-24 | 21.24x |
| 2026-02-23 | 21.27x |
| 2026-02-20 | 21.07x |
| 2026-02-19 | 21.22x |
| 2026-02-18 | 21.17x |
| 2026-02-17 | 20.75x |
| 2026-02-13 | 20.86x |
| 2026-02-12 | 21.04x |
| 2026-02-11 | 21.65x |
| 2026-02-10 | 22.09x |
| 2026-02-09 | 22.33x |
| 2026-02-06 | 22.20x |
| 2026-02-05 | 22.18x |
| 2026-02-04 | 22.98x |
| 2026-02-03 | 23.15x |
| 2026-02-02 | 23.56x |
| 2026-01-30 | 23.45x |
| 2026-01-29 | 23.93x |
| 2026-01-28 | 24.48x |
| 2026-01-27 | 25.04x |
| 2026-01-26 | 25.14x |
| 2026-01-23 | 25.12x |
| 2026-01-22 | 25.59x |
| 2026-01-21 | 25.48x |
| 2026-01-20 | 24.87x |
| 2026-01-16 | 24.86x |
| 2026-01-15 | 25.07x |
| 2026-01-14 | 24.97x |
| 2026-01-13 | 24.45x |
| 2026-01-12 | 24.75x |
| 2026-01-09 | 24.87x |
| 2026-01-08 | 24.43x |
| 2026-01-07 | 24.81x |
| 2026-01-06 | 24.93x |
| 2026-01-05 | 24.60x |
| 2026-01-02 | 23.94x |
| 2025-12-31 | 23.48x |
| 2025-12-30 | 23.62x |
| 2025-12-29 | 23.68x |
| 2025-12-26 | 23.53x |
| 2025-12-24 | 23.47x |
| 2025-12-23 | 23.50x |
| 2025-12-22 | 23.35x |
| 2025-12-19 | 23.07x |
| 2025-12-18 | 22.88x |
| 2025-12-17 | 22.89x |
| 2025-12-16 | 23.16x |
| 2025-12-15 | 23.36x |
| 2025-12-12 | 23.23x |
| 2025-12-11 | 23.46x |
| 2025-12-10 | 23.28x |
| 2025-12-09 | 22.91x |
| 2025-12-08 | 23.09x |
| 2025-12-05 | 23.25x |
| 2025-12-04 | 23.33x |
| 2025-12-03 | 23.52x |
| 2025-12-02 | 23.51x |
| 2025-12-01 | 23.68x |
| 2025-11-28 | 23.88x |
| 2025-11-26 | 23.97x |
| 2025-11-25 | 24.13x |
| 2025-11-24 | 23.71x |
| 2025-11-21 | 23.76x |
| 2025-11-20 | 23.25x |
| 2025-11-19 | 23.28x |
| 2025-11-18 | 23.36x |
| 2025-11-17 | 23.05x |
| 2025-11-14 | 23.46x |
| 2025-11-13 | 23.51x |
| 2025-11-12 | 23.78x |
| 2025-11-11 | 23.73x |
| 2025-11-10 | 23.37x |
| 2025-11-07 | 23.23x |
| 2025-11-06 | 23.01x |
| 2025-11-05 | 23.07x |
| 2025-11-04 | 22.98x |
| 2025-11-03 | 22.97x |
| 2025-10-31 | 22.67x |
| 2025-10-30 | 22.28x |
| 2025-10-29 | 22.35x |
| 2025-10-28 | 22.33x |
| 2025-10-27 | 22.54x |
| 2025-10-24 | 22.85x |
| 2025-10-23 | 22.83x |
| 2025-10-22 | 22.66x |
| 2025-10-21 | 22.34x |
| 2025-10-20 | 21.85x |
| 2025-10-17 | 21.67x |
| 2025-10-16 | 21.60x |
| 2025-10-15 | 21.29x |
| 2025-10-14 | 21.22x |
| 2025-10-13 | 21.17x |
| 2025-10-10 | 21.18x |
| 2025-10-09 | 21.53x |
| 2025-10-08 | 21.58x |
| 2025-10-07 | 21.68x |
| 2025-10-06 | 21.85x |
| 2025-10-03 | 21.83x |
| 2025-10-02 | 21.19x |
| 2025-10-01 | 21.39x |
| 2025-09-30 | 19.79x |
| 2025-09-29 | 18.99x |
| 2025-09-26 | 19.06x |
| 2025-09-25 | 18.89x |
| 2025-09-24 | 19.20x |
| 2025-09-23 | 19.26x |
| 2025-09-22 | 19.44x |
| 2025-09-19 | 19.60x |
| 2025-09-18 | 19.65x |
| 2025-09-17 | 19.36x |
| 2025-09-16 | 19.64x |
| 2025-09-15 | 19.42x |
| 2025-09-12 | 19.60x |
| 2025-09-11 | 20.01x |
| 2025-09-10 | 19.49x |
| 2025-09-09 | 19.70x |
| 2025-09-08 | 19.88x |
| 2025-09-05 | 20.06x |
| 2025-09-04 | 19.95x |
| 2025-09-03 | 19.77x |
| 2025-09-02 | 19.88x |
| 2025-08-29 | 20.06x |
| 2025-08-28 | 19.96x |
| 2025-08-27 | 19.90x |
Showing the most recent 260 of 5,030 data points. The chart above shows the full history.
